CN116573999A - Alpha-hydroxy organic acid-amino acid and analogue divalent metal co-salt compound thereof, and preparation method and application thereof - Google Patents
Alpha-hydroxy organic acid-amino acid and analogue divalent metal co-salt compound thereof, and preparation method and application thereof Download PDFInfo
- Publication number
- CN116573999A CN116573999A CN202310341680.2A CN202310341680A CN116573999A CN 116573999 A CN116573999 A CN 116573999A CN 202310341680 A CN202310341680 A CN 202310341680A CN 116573999 A CN116573999 A CN 116573999A
- Authority
- CN
- China
- Prior art keywords
- acid
- divalent metal
- alpha
- hydroxy organic
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052751 metal Inorganic materials 0.000 title claims abstract description 72
- 239000002184 metal Substances 0.000 title claims abstract description 68
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 239000007864 aqueous solution Substances 0.000 claims abstract description 118
- 238000006243 chemical reaction Methods 0.000 claims abstract description 115
- 239000007787 solid Substances 0.000 claims abstract description 47
- 235000008206 alpha-amino acids Nutrition 0.000 claims abstract description 19
- 150000002736 metal compounds Chemical class 0.000 claims abstract description 16
- 238000000227 grinding Methods 0.000 claims abstract description 3
- 238000007873 sieving Methods 0.000 claims abstract description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 90
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 88
- 229940024606 amino acid Drugs 0.000 claims description 57
- 239000004471 Glycine Substances 0.000 claims description 44
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 claims description 35
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 32
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 31
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 claims description 31
- 239000000174 gluconic acid Substances 0.000 claims description 31
- 235000012208 gluconic acid Nutrition 0.000 claims description 31
- 239000001630 malic acid Substances 0.000 claims description 31
- 235000011090 malic acid Nutrition 0.000 claims description 31
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 26
- 235000015165 citric acid Nutrition 0.000 claims description 26
- 235000001014 amino acid Nutrition 0.000 claims description 25
- 150000001413 amino acids Chemical class 0.000 claims description 25
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 20
- 238000001035 drying Methods 0.000 claims description 20
- 229910052791 calcium Inorganic materials 0.000 claims description 18
- 239000011575 calcium Substances 0.000 claims description 18
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 15
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 15
- 229910052802 copper Inorganic materials 0.000 claims description 15
- 239000010949 copper Substances 0.000 claims description 15
- 229910052749 magnesium Inorganic materials 0.000 claims description 15
- 239000011777 magnesium Substances 0.000 claims description 15
- 239000011701 zinc Substances 0.000 claims description 15
- 229910052725 zinc Inorganic materials 0.000 claims description 15
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 14
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims description 13
- 229910052742 iron Inorganic materials 0.000 claims description 13
- 150000003839 salts Chemical class 0.000 claims description 13
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 12
- 229910052748 manganese Inorganic materials 0.000 claims description 12
- 239000011572 manganese Substances 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 239000003446 ligand Substances 0.000 claims description 9
- 244000144977 poultry Species 0.000 claims description 8
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 6
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 6
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 5
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
- 239000004473 Threonine Substances 0.000 claims description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 4
- 229960002989 glutamic acid Drugs 0.000 claims description 4
- 229960000310 isoleucine Drugs 0.000 claims description 4
- 229960003136 leucine Drugs 0.000 claims description 4
- 229960003080 taurine Drugs 0.000 claims description 4
- 229960002898 threonine Drugs 0.000 claims description 4
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 claims description 3
- ONFOSYPQQXJWGS-UHFFFAOYSA-N 2-hydroxy-4-(methylthio)butanoic acid Chemical compound CSCCC(O)C(O)=O ONFOSYPQQXJWGS-UHFFFAOYSA-N 0.000 claims description 3
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 3
- 229930182844 L-isoleucine Natural products 0.000 claims description 3
- 239000004395 L-leucine Substances 0.000 claims description 3
- 235000019454 L-leucine Nutrition 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 3
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 claims description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 40
- -1 salt compound Chemical class 0.000 abstract description 30
- 150000001875 compounds Chemical class 0.000 abstract description 26
- 239000000243 solution Substances 0.000 abstract description 13
- 150000001371 alpha-amino acids Chemical class 0.000 abstract description 6
- 229940088594 vitamin Drugs 0.000 abstract description 6
- 235000013343 vitamin Nutrition 0.000 abstract description 6
- 239000011782 vitamin Substances 0.000 abstract description 6
- 229930003231 vitamin Natural products 0.000 abstract description 6
- 238000004090 dissolution Methods 0.000 abstract description 5
- 238000003911 water pollution Methods 0.000 abstract description 4
- 239000003674 animal food additive Substances 0.000 abstract description 3
- 239000013078 crystal Substances 0.000 description 37
- 239000000843 powder Substances 0.000 description 33
- 238000003756 stirring Methods 0.000 description 33
- 229960004106 citric acid Drugs 0.000 description 24
- 235000002639 sodium chloride Nutrition 0.000 description 21
- 239000000047 product Substances 0.000 description 20
- 239000008367 deionised water Substances 0.000 description 18
- 229910021641 deionized water Inorganic materials 0.000 description 18
- 229960005069 calcium Drugs 0.000 description 16
- 229940108928 copper Drugs 0.000 description 13
- 229940091250 magnesium supplement Drugs 0.000 description 13
- MTJGVAJYTOXFJH-UHFFFAOYSA-N 3-aminonaphthalene-1,5-disulfonic acid Chemical compound C1=CC=C(S(O)(=O)=O)C2=CC(N)=CC(S(O)(=O)=O)=C21 MTJGVAJYTOXFJH-UHFFFAOYSA-N 0.000 description 12
- 238000004321 preservation Methods 0.000 description 12
- 239000011573 trace mineral Substances 0.000 description 12
- 235000013619 trace mineral Nutrition 0.000 description 12
- 229940071566 zinc glycinate Drugs 0.000 description 12
- 229960003284 iron Drugs 0.000 description 11
- 241001465754 Metazoa Species 0.000 description 10
- 229940004916 magnesium glycinate Drugs 0.000 description 8
- OKOYFIHZDKMHAM-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;manganese Chemical compound [Mn].OC(=O)CC(O)(C(O)=O)CC(O)=O OKOYFIHZDKMHAM-UHFFFAOYSA-N 0.000 description 6
- 229960004543 anhydrous citric acid Drugs 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 229960004452 methionine Drugs 0.000 description 6
- RUWKZSPFMDVLRC-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;zinc Chemical compound [Zn].OC(=O)CC(O)(C(O)=O)CC(O)=O RUWKZSPFMDVLRC-UHFFFAOYSA-N 0.000 description 5
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 5
- 235000005985 organic acids Nutrition 0.000 description 5
- ROYPGAQNKYWYDI-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;magnesium Chemical compound [Mg].OC(=O)CC(O)(C(O)=O)CC(O)=O ROYPGAQNKYWYDI-UHFFFAOYSA-N 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 4
- 239000001362 calcium malate Substances 0.000 description 4
- 229940016114 calcium malate Drugs 0.000 description 4
- 235000011038 calcium malates Nutrition 0.000 description 4
- QXDHJHQRJCJRAU-UHFFFAOYSA-N calcium;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Ca].OC(=O)CC(O)(C(O)=O)CC(O)=O QXDHJHQRJCJRAU-UHFFFAOYSA-N 0.000 description 4
- 235000002538 magnesium citrate Nutrition 0.000 description 4
- 229960005336 magnesium citrate Drugs 0.000 description 4
- 239000004337 magnesium citrate Substances 0.000 description 4
- 229930182817 methionine Natural products 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000006104 solid solution Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- PLSARIKBYIPYPF-UHFFFAOYSA-H trimagnesium dicitrate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O PLSARIKBYIPYPF-UHFFFAOYSA-H 0.000 description 4
- KFSJYZYQSZKRRQ-BYPYZUCNSA-N (2s)-2-(hydroxyamino)-4-methylsulfanylbutanoic acid Chemical compound CSCC[C@H](NO)C(O)=O KFSJYZYQSZKRRQ-BYPYZUCNSA-N 0.000 description 3
- 229910017053 inorganic salt Inorganic materials 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 239000013049 sediment Substances 0.000 description 3
- 239000011670 zinc gluconate Substances 0.000 description 3
- 235000011478 zinc gluconate Nutrition 0.000 description 3
- 229960000306 zinc gluconate Drugs 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- KRUJOKMDEHYPOP-UHFFFAOYSA-L 2-hydroxybutanedioate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)C(O)CC([O-])=O KRUJOKMDEHYPOP-UHFFFAOYSA-L 0.000 description 2
- CLWNPUARORRDFD-UHFFFAOYSA-N 2-hydroxybutanedioic acid;zinc Chemical compound [Zn].OC(=O)C(O)CC(O)=O CLWNPUARORRDFD-UHFFFAOYSA-N 0.000 description 2
- OAVRWNUUOUXDFH-UHFFFAOYSA-H 2-hydroxypropane-1,2,3-tricarboxylate;manganese(2+) Chemical compound [Mn+2].[Mn+2].[Mn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O OAVRWNUUOUXDFH-UHFFFAOYSA-H 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 2
- QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 2
- 239000005751 Copper oxide Substances 0.000 description 2
- 241000277275 Oncorhynchus mykiss Species 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 2
- 239000001354 calcium citrate Substances 0.000 description 2
- 239000004227 calcium gluconate Substances 0.000 description 2
- 235000013927 calcium gluconate Nutrition 0.000 description 2
- 229960004494 calcium gluconate Drugs 0.000 description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000013522 chelant Substances 0.000 description 2
- 229940108925 copper gluconate Drugs 0.000 description 2
- 229910000431 copper oxide Inorganic materials 0.000 description 2
- WMYBXRITVYIFCO-UHFFFAOYSA-N copper;2-hydroxybutanedioic acid Chemical compound [Cu].OC(=O)C(O)CC(O)=O WMYBXRITVYIFCO-UHFFFAOYSA-N 0.000 description 2
- JQKUCPUQTWLCNU-UHFFFAOYSA-N copper;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Cu].OC(=O)CC(O)(C(O)=O)CC(O)=O JQKUCPUQTWLCNU-UHFFFAOYSA-N 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- 239000011641 cupric citrate Substances 0.000 description 2
- 235000019855 cupric citrate Nutrition 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 239000011640 ferrous citrate Substances 0.000 description 2
- 235000019850 ferrous citrate Nutrition 0.000 description 2
- 239000004222 ferrous gluconate Substances 0.000 description 2
- 235000013924 ferrous gluconate Nutrition 0.000 description 2
- 229960001645 ferrous gluconate Drugs 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- APVZWAOKZPNDNR-UHFFFAOYSA-L iron(ii) citrate Chemical compound [Fe+2].OC(=O)CC(O)(C([O-])=O)CC([O-])=O APVZWAOKZPNDNR-UHFFFAOYSA-L 0.000 description 2
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 2
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 2
- 239000001755 magnesium gluconate Substances 0.000 description 2
- 235000015778 magnesium gluconate Nutrition 0.000 description 2
- 229960003035 magnesium gluconate Drugs 0.000 description 2
- 239000000347 magnesium hydroxide Substances 0.000 description 2
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 2
- JFQQIWNDAXACSR-UHFFFAOYSA-L magnesium malate Chemical compound [Mg+2].[O-]C(=O)C(O)CC([O-])=O JFQQIWNDAXACSR-UHFFFAOYSA-L 0.000 description 2
- 229940096424 magnesium malate Drugs 0.000 description 2
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 2
- 239000011564 manganese citrate Substances 0.000 description 2
- 235000014872 manganese citrate Nutrition 0.000 description 2
- 229940097206 manganese citrate Drugs 0.000 description 2
- IPJKJLXEVHOKSE-UHFFFAOYSA-L manganese dihydroxide Chemical compound [OH-].[OH-].[Mn+2] IPJKJLXEVHOKSE-UHFFFAOYSA-L 0.000 description 2
- 239000011683 manganese gluconate Substances 0.000 description 2
- 235000014012 manganese gluconate Nutrition 0.000 description 2
- 229940072543 manganese gluconate Drugs 0.000 description 2
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 2
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- VASIZKWUTCETSD-UHFFFAOYSA-N oxomanganese Chemical compound [Mn]=O VASIZKWUTCETSD-UHFFFAOYSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000013337 tricalcium citrate Nutrition 0.000 description 2
- STDMRMREKPZQFJ-UHFFFAOYSA-H tricopper;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[Cu+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O STDMRMREKPZQFJ-UHFFFAOYSA-H 0.000 description 2
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 2
- 229960004295 valine Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000011746 zinc citrate Substances 0.000 description 2
- 235000006076 zinc citrate Nutrition 0.000 description 2
- 229940068475 zinc citrate Drugs 0.000 description 2
- ZSKINHGFQOKUDM-IYEMJOQQSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoic acid;zinc Chemical compound [Zn].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O ZSKINHGFQOKUDM-IYEMJOQQSA-N 0.000 description 1
- QSVWKBUDZWXCAX-UHFFFAOYSA-N 2-hydroxybutanedioic acid;hydrate Chemical compound O.OC(=O)C(O)CC(O)=O QSVWKBUDZWXCAX-UHFFFAOYSA-N 0.000 description 1
- PICCHNWCTUUCAQ-UHFFFAOYSA-N 2-hydroxypentanethioic s-acid Chemical compound CCCC(O)C(O)=S PICCHNWCTUUCAQ-UHFFFAOYSA-N 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- JJLJMEJHUUYSSY-UHFFFAOYSA-L Copper hydroxide Chemical compound [OH-].[OH-].[Cu+2] JJLJMEJHUUYSSY-UHFFFAOYSA-L 0.000 description 1
- 239000005750 Copper hydroxide Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004277 Ferrous carbonate Substances 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229930195722 L-methionine Natural products 0.000 description 1
- 241000530268 Lycaena heteronea Species 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000007824 aliphatic compounds Chemical class 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000005550 amino acid supplement Nutrition 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037180 bone health Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- NEEHYRZPVYRGPP-IYEMJOQQSA-L calcium gluconate Chemical compound [Ca+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O NEEHYRZPVYRGPP-IYEMJOQQSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910001956 copper hydroxide Inorganic materials 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 229940011405 cupric glycinate Drugs 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000006052 feed supplement Substances 0.000 description 1
- 235000019268 ferrous carbonate Nutrition 0.000 description 1
- RAQDACVRFCEPDA-UHFFFAOYSA-L ferrous carbonate Chemical compound [Fe+2].[O-]C([O-])=O RAQDACVRFCEPDA-UHFFFAOYSA-L 0.000 description 1
- 229960004652 ferrous carbonate Drugs 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 229910000015 iron(II) carbonate Inorganic materials 0.000 description 1
- 239000010871 livestock manure Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- UGZADUVQMDAIAO-UHFFFAOYSA-L zinc hydroxide Chemical compound [OH-].[OH-].[Zn+2] UGZADUVQMDAIAO-UHFFFAOYSA-L 0.000 description 1
- 229910021511 zinc hydroxide Inorganic materials 0.000 description 1
- 229940007718 zinc hydroxide Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/41—Preparation of salts of carboxylic acids
- C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
- C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/24—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one carboxyl group bound to the carbon skeleton, e.g. aspartic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
- C07C303/32—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of salts of sulfonic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
- C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
- C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
- C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
- Y02A40/81—Aquaculture, e.g. of fish
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The invention relates to the technical field of feed additives, in particular to an alpha-hydroxy organic acid-amino acid and analogue divalent metal salt compound, a preparation method and application thereof, wherein an alpha-hydroxy organic acid aqueous solution and a divalent metal compound react for 0.5-3 hours at the reaction temperature of 60-100 ℃, the alpha-amino acid and analogue thereof are added into the obtained mixed aqueous solution, the mixed aqueous solution reacts for 1-4 hours at the reaction temperature of 70-110 ℃, the reaction solution is decompressed and concentrated to be solid, the solid is dried to be constant weight, and the alpha-hydroxy organic acid-amino acid and analogue divalent metal salt compound thereof is obtained through grinding and sieving. The divalent metal, the alpha-hydroxy organic acid, the alpha-amino acid and the analogues thereof are delivered by a single water-soluble dosage unit, and a plurality of components are required to be mixed or combined, so that the dissolution loss of the alpha-hydroxy organic acid, the alpha-amino acid and the analogues thereof in the feed in a water environment can be avoided, the water pollution is further avoided, and the damage of the divalent metal to vitamins and fatty compounds in the feed is avoided.
Description
Technical Field
The invention relates to the technical field of feed additives, in particular to an alpha-hydroxy organic acid-amino acid and analogue divalent metal salt compound thereof, and a preparation method and application thereof.
Background
Divalent metals (e.g., calcium, magnesium, zinc, copper, iron, manganese) are important to animal health. The importance of calcium in cell biochemistry is well known. Also well known is the importance of trace minerals (e.g., magnesium, zinc, copper, iron, manganese) to animal health. For example, many studies have shown that zinc has a direct relationship with animal immune organs and plays an important role in maintaining the structure and function of the animal central immune organs thymus, supraluminal and peripheral immune organs spleen, lymph nodes, tonsils. The growth and development are the basis of all production of poultry, and trace elements play a very important role in the production. Some trace elements are used as the material basis of growth and development to participate in organism constitution, such as manganese, copper, zinc and the like; some trace elements are used as main participants of cell growth metabolism in the growth and development process of poultry, for example, iron carries oxygen to participate in various chemical reactions in cells on one hand, and on the other hand, the iron is used as an output tool of carbon dioxide; some trace elements exist as promoters of various enzymes, hormones, etc. active substances in poultry, such as zinc, selenium, etc. In a word, the growth and development of the poultry are not separated from the participation of trace elements, and the body can only keep proper trace elements to ensure healthy growth and development.
At the same time, other compounds are also important, and the presence of these compounds can promote the absorption of the above divalent metal elements, especially in a manner of complexing (chelating) these compounds with the metal elements. D, L-2-hydroxy-4-methylthiobutanoic acid, also known as methionine hydroxy analogue (hydroxy methionine), is mainly used as feed supplement for methionine supplementation. Hydroxy methionine has been used in animal husbandry as early as fifty in the last century, and has been confirmed by feed industry, animal husbandry and pet manufacturers to be an excellent methionine source with biological effects equivalent to equimolar amounts of D, L-methionine and L-methionine. Other amino acids such as glycine are believed to help reduce oxidative stress by producing glutathione in the body. In addition, glycine is used by the body to produce creatine, a substance that has been shown to increase muscle size, strength and capacity. The beneficial effects of glycine on bone health, brain function and neurological conditions were also investigated. Glycine is the major component of collagen, which is known to promote skin health, relieve joint pain and prevent bone loss. The benefits of alpha-hydroxy organic acids such as malic acid, citric acid, gluconic acid are well known and documented.
The organic microelements (zinc, copper, iron and manganese) and the medium-major elements of calcium and magnesium can improve the growth performance of animals, enhance the immunity and the anti-stress capability, reduce the environmental pollution, and are a green and efficient feed additive with very broad application prospect. The use of alpha-hydroxy organic acid metal salts and bis alpha-amino acid metal chelates alone generally results in less desirable properties or performance. For example, organic acid salts such as tribasic magnesium citrate, calcium malate, etc., exhibit too high water solubility, while bis-alpha-amino acid metal chelates exhibit poor water solubility, either of which are difficult to compress in tableting applications due to low compressibility. Alpha-hydroxy organic acid metal salts such as magnesium citrate, calcium malate and zinc gluconate have poor stability and low metal content due to good water solubility, but are unfavorable for absorption by animals. The alpha-amino acid metal chelates, although poorly water soluble, have a lower dissolution rate in water, however, the molecular structure also shows a higher stability constant, which results in a slow rate of dissociation of such metal chelates into metal ions and free amino acids in animals, requiring dissociation under strong acid conditions, resulting in slower absorption, and ensuring sufficient residence time in animal intestines and stomach for adequate absorption, which may limit their use in feed applications. Currently, most of the feeds on the market are direct mixtures of divalent metal salts with organic acids or amino acids, and lack a compound which can deliver amino acids such as methionine and minerals by ingestion.
Disclosure of Invention
In view of the above, the present invention aims to provide an α -hydroxy organic acid-amino acid and its analogues divalent metal co-salt compound, and a preparation method and application thereof, wherein divalent metals, α -hydroxy organic acids and α -amino acids and its analogues are delivered in a single water-soluble dosage unit, and multiple components are required to be mixed or combined, so that dissolution loss of α -hydroxy organic acids, α -amino acids and its analogues in a water environment in a feed can be avoided, and further water pollution is avoided, and damage of divalent metals to vitamins and fatty compounds in the feed is avoided.
The invention solves the technical problems by the following technical means:
an aspect of the present invention is to provide an α -hydroxy organic acid-amino acid and its analog divalent metal co-salt compound having the following general structure:
wherein M is any one of calcium, magnesium, zinc, copper, iron and manganese; r1 and alpha-hydroxy carboxyl can form alpha-hydroxy organic acid, R2 and alpha-amino carboxyl can form alpha-amino acid and amino acid analogues thereof, x is 0.5 or 1, y is 1 or 2, and z is 0-2.
Further, the alpha-hydroxy organic acid is any one of citric acid, malic acid and gluconic acid; the alpha-amino acid is any one of glycine, D, L-methionine, L-threonine, L-glutamic acid, L-lysine, L-tryptophan, L-phenylalanine, L-isoleucine, L-leucine and L-valine; the amino acid analogue is any one of 2-hydroxy-4-methylthiobutanoic acid and taurine.
In still another aspect of the present invention, there is provided a method for preparing the above-mentioned α -hydroxy organic acid-amino acid and its analog divalent metal co-salt compound, the method comprising the steps of:
reacting the alpha-hydroxy organic acid aqueous solution with the divalent metal compound for 0.5-3 h at the reaction temperature of 60-100 ℃ and the pH value of 7.0-12 to obtain a mixed aqueous solution of the divalent metal salt of the alpha-hydroxy organic acid and the divalent metal compound;
adding alpha-amino acid and analogues thereof into the mixed aqueous solution of the divalent metal salt and the divalent metal compound of the alpha-hydroxy organic acid, and reacting for 1-4 hours at the reaction temperature of 70-110 ℃ with the pH value of 6.0-11 to obtain the mixed aqueous solution of the divalent metal co-salt compound of the alpha-hydroxy organic acid-amino acid and analogues thereof;
concentrating the mixed aqueous solution of the alpha-hydroxy organic acid-amino acid and the analogue divalent metal co-salt compound to be solid under reduced pressure, drying to be constant weight, grinding and sieving to obtain the alpha-hydroxy organic acid-amino acid and the analogue divalent metal co-salt compound.
Further, the divalent metal compound is an oxide or hydroxide or carbonate of any one of calcium, magnesium, zinc, copper, iron, and manganese.
Further, the molar ratio of the alpha-hydroxy organic acid to the alpha-amino acid and the analogues thereof is 0.5-1:1, and the molar ratio of the ligand formed by the alpha-hydroxy organic acid to the alpha-amino acid and the analogues thereof to the divalent metal is 1:1-2.
Further, when the α -hydroxy organic acid is citric acid, the molar ratio of the α -hydroxy organic acid to the amino acid and analogs thereof is 1:1, and the molar ratio of the ligand to the divalent metal compound is 1:1.
Further, when the α -hydroxy organic acid is malic acid, the molar ratio of the α -hydroxy organic acid to the amino acid and analogues thereof is 0.5:1, and the molar ratio of the ligand to the divalent metal compound is 1.5:1.
Further, when the α -hydroxy organic acid is gluconic acid, the molar ratio of the α -hydroxy organic acid to the amino acid and the analogues thereof is 1:1, and the molar ratio of the divalent metal compound to the ligand is 2:1.
In a further aspect, the invention provides the use of the above-mentioned alpha-hydroxy organic acid-amino acid and analogues thereof as an additive in the preparation of aquatic feed or poultry feed.
The invention has the following beneficial effects:
(1) Compared with the monomer free amino acid, inorganic divalent metal salt and single alpha-hydroxy organic acid metal salt, the alpha-hydroxy organic acid-amino acid and analogue divalent metal salt compound has a special structure, the water solubility of the alpha-hydroxy organic acid-amino acid and analogue divalent metal salt compound is obviously reduced (the solubility of the alpha-hydroxy organic acid-amino acid and analogue divalent metal salt compound is less than 1.5 g/100 ml of water (20 ℃)), the dissolution loss of amino acid, alpha-hydroxy organic acid and divalent metal ions in the feed in the water environment is avoided, the water pollution is further avoided, and the damage of divalent metal to vitamins and aliphatic compounds in the feed is avoided.
(2) The alpha-hydroxy organic acid-amino acid and analogue divalent metal salt compound can be used as an alpha-hydroxy organic acid supplement, can be used as an amino acid supplement and a metal element supplement, is flexibly matched, and can greatly reduce the use of divalent metal elements in aquatic feeds and poultry feeds, reduce the feed cost, improve the bioavailability of the divalent metal elements, reduce the metal content in livestock manure and reduce the environmental pollution.
(3) Compared with the traditional single amino acid complex (chelate) divalent metal salt, the alpha-hydroxy organic acid-amino acid and analogue divalent metal salt compound of the invention takes the alpha-hydroxy organic acid as a base segment, can flexibly combine with other amino acids and analogues thereof, has simple synthesis and better effect than the single alpha-hydroxy organic acid or amino acid complex (chelate) divalent metal salt.
Drawings
FIG. 1 is a general structure of an α -hydroxy organic acid-amino acid and its analog divalent metal co-salt compound of the present invention;
FIG. 2 is a synthetic route diagram of the α -hydroxy organic acid-amino acid and its analog divalent metal co-salt compound of the present invention;
FIG. 3 is a chemical structure of a divalent metal co-salt compound of the present invention based on citric acid;
FIG. 4 is a chemical structure of a divalent metal co-salt compound of the present invention having malic acid as a base;
FIG. 5 shows the chemical structure of a divalent metal co-salt compound of the present invention having gluconic acid as a substrate.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
The following examples were conducted under conventional conditions or conditions recommended by the manufacturer, without specifying the specific conditions. The raw materials, equipment or instruments used are conventional products commercially available without identifying the manufacturer.
The divalent metal salt compound taking hydroxy methionine as a substrate has a general structure shown in figure 1, wherein M is metal and R in the general structure shown in figure 1 1 With alpha-hydroxy carboxyl groups to form alpha-hydroxy organic acids, or R 2 With the alpha-amino carboxyl group, to form alpha-amino acids and amino acid analogues, such as 2-hydroxy-4-methylthiobutanoic acid and taurine. Specifically, M is any one of calcium, magnesium, zinc, copper, iron and manganese, R 1 Can form any one of citric acid, malic acid and gluconic acid with alpha-hydroxy carboxyl; r is R 2 And the alpha-amino carboxyl group forms any one of glycine, D, L-methionine, L-threonine, L-lysine, L-glutamic acid, L-tryptophan, L-phenylalanine, L-isoleucine, L-leucine and L-valine. The molar ratio of the alpha-hydroxy organic acid to the amino acid in the divalent metal salt compound taking the alpha-hydroxy organic acid as the substrate is 0.5:1 or 1:1, the molar ratio of the ligand to the divalent metal is 1:1-2, and the number of crystal water in the compound is 0-2. The preparation method of the divalent metal co-salt compound of alpha-hydroxy organic acid-amino acid and the analogues thereof of the present invention follows the reaction route shown in fig. 2. Specific preparation methods are shown in examples 1-20.
EXAMPLE 1 preparation of calcium citrate-glycinate Co-salt
194.07 g (1.0 mol) of anhydrous citric acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and citric acid is completely dissolved, so that a citric acid aqueous solution with the mass percent of 24.82% is obtained. 116.67 g (2.0 mol) of calcium oxide powder with the mass percent of 96% is added into the citric acid aqueous solution, the reaction temperature is raised to 80 ℃, the reaction is carried out for 1h under the condition of heat preservation and stirring, and the pH value of the reaction system is 12, thus obtaining the milky calcium citrate aqueous solution. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the calcium citrate aqueous solution, the temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 2 hours, the pH value of the reaction system is 9, and the citric acid-calcium glycinate compound aqueous solution is obtained. The obtained aqueous solution of the citric acid-calcium glycine co-salt compound is directly concentrated to be solid under reduced pressure, then all the aqueous solution is transferred into a tray, and the tray is put into a blast drying oven at 105 ℃ to be dried to constant weight, thus 386.87 g of white solid powder of the citric acid-calcium glycine co-salt compound is obtained, the mass percentage of calcium in the product is 20.68%, and the yield is calculated to be 100%.
EXAMPLE 2 preparation of magnesium citrate-glycinate Co-salt
194.07 g (1.0 mol) of anhydrous citric acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and citric acid is completely dissolved, so that a citric acid aqueous solution with the mass percent of 24.82% is obtained. 81.42 g (2.0 mol) of magnesium oxide powder with the mass percent of 99% is added into the citric acid aqueous solution, the reaction temperature is raised to 75 ℃, the reaction is carried out for 1h under the condition of heat preservation and stirring, and the pH value of the reaction system is 11, thus obtaining milky magnesium citrate aqueous solution. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the magnesium citrate aqueous solution, the temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 2 hours, the pH value of the reaction system is 8.0, and the citric acid-magnesium glycinate compound aqueous solution is obtained. The obtained aqueous solution of the citric acid-magnesium glycinate compound is directly concentrated to be solid under reduced pressure, then all the aqueous solution is transferred into a tray, and the tray is put into a blast drying oven at 105 ℃ to be dried to constant weight, thus 354.21 g of white solid powder of the citric acid-magnesium glycinate compound is obtained, the mass percentage of magnesium in the product is 13.55%, and the yield is calculated to be 100%.
EXAMPLE 3 preparation of Zinc citrate-glycinate Co-salts
194.07 g (1.0 mol) of anhydrous citric acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and citric acid is completely dissolved, so that a citric acid aqueous solution with the mass percent of 24.82% is obtained. 164.42 g (2.0 mol) of zinc oxide powder with the mass percent of 99% is added into the citric acid aqueous solution, the reaction temperature is raised to 100 ℃, the reaction is carried out for 3 hours under heat preservation and stirring, and the pH value of the reaction system is 8.5, thus obtaining milky zinc citrate aqueous solution. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the zinc citrate aqueous solution, the temperature is raised to 110 ℃, the temperature is kept, the stirring reaction is carried out for 4 hours, the pH of the reaction system is 6.5, and the citric acid-zinc glycinate compound aqueous solution is obtained. The obtained aqueous solution of the citric acid-zinc glycinate compound is directly concentrated to be solid under reduced pressure, then the solid solution is completely transferred into a tray, and the tray is put into a blast drying oven at 100 ℃ to be dried to constant weight, thus 442.40 g of white solid powder of the citric acid-zinc glycinate compound is obtained, the mass percentage of zinc in the product is 29.38%, and the yield is calculated to be 100%.
EXAMPLE 4 preparation of copper citrate-glycinate Co-salts
194.07 g (1.0 mol) of anhydrous citric acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and citric acid is completely dissolved, so that a citric acid aqueous solution with the mass percent of 24.82% is obtained. 201.03 g (2.0 mol) of copper hydroxide blue powder with the mass percent of 97% is added into the citric acid aqueous solution, the reaction temperature is increased to 95 ℃, the reaction is carried out for 0.5h under the condition of heat preservation and stirring, and the pH value of the reaction system is 7.5, thus obtaining blue cupric citrate aqueous solution. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the cupric citrate aqueous solution, the temperature is raised to 110 ℃, the temperature is kept, the stirring reaction is carried out for 1h, the pH value of the reaction system is 6.0, and the blue citric acid-cupric glycinate common salt compound aqueous solution is obtained. The obtained aqueous solution of the citric acid-copper glycinate compound is directly decompressed and concentrated to be solid, then the solid is completely transferred into a tray, and the tray is put into a blast drying oven at 100 ℃ to be dried to constant weight, 439.41 g of blue solid powder of the citric acid-zinc glycinate compound is obtained, the mass percentage of copper in the product is 28.93%, and the yield is calculated to be 100%.
EXAMPLE 5 preparation of citric acid-ferrous Glycine Co-salt
194.07 g (1.0 mol) of anhydrous citric acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and citric acid is completely dissolved, so that a citric acid aqueous solution with the mass percent of 24.82% is obtained. 238.87 g (2.0 mol) of ferrous carbonate white powder with the mass percent of 97% is added into the citric acid aqueous solution, the reaction temperature is raised to 85 ℃, the reaction is carried out for 2 hours with heat preservation and stirring, and the pH value of the reaction system is 7.5, thus obtaining a light yellow ferrous citrate aqueous solution. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the ferrous citrate aqueous solution, the temperature is raised to 95 ℃, the temperature is kept, the stirring reaction is carried out for 2 hours, the pH value of the reaction system is 6.0, and the yellowish citric acid-ferrous glycine co-salt compound aqueous solution is obtained. The obtained aqueous solution of the citric acid-ferrous glycine co-salt compound is directly concentrated to be solid under reduced pressure, then the solid solution is completely transferred into a tray, and the tray is put into a blast drying oven at 100 ℃ to be dried to constant weight, thus 432.77 g of the citric acid-ferrous glycine co-salt compound light yellow solid powder is obtained, the mass percentage of iron in the product is 25.88%, and the yield is calculated to be 100%.
EXAMPLE 6 preparation of citric acid-manganese Glycine Co-salt
194.07 g (1.0 mol) of anhydrous citric acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and citric acid is completely dissolved, so that a citric acid aqueous solution with the mass percent of 24.82% is obtained. To the aqueous solution of citric acid, 187.26 g (2.0 mol) of 95% by mass of white manganese hydroxide powder was added, the reaction temperature was raised to 85 ℃, and the mixture was stirred at a constant temperature for 2 hours to obtain a pale gray aqueous solution of manganese citrate with a pH of 7.0. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the manganese citrate aqueous solution, the temperature is raised to 95 ℃, the temperature is kept, the stirring reaction is carried out for 2 hours, the pH value of the reaction system is 5.5, and the light gray citric acid-manganese glycinate co-salt compound aqueous solution is obtained. The obtained aqueous solution of the citric acid-manganese glycinate compound is directly concentrated to be solid under reduced pressure, then the solid solution is completely transferred into a tray, and the tray is put into a blast drying oven at 100 ℃ to be dried to constant weight, thus 426.18 g of the off-white solid powder of the citric acid-manganese glycinate compound is obtained, the mass percentage of manganese in the product is 25.81%, and the yield is calculated to be 100%.
According to the above method, a citric acid-methionine salt compound, a citric acid-threonine salt compound, a citric acid-glutamic acid salt compound, a citric acid-lysine salt compound, a citric acid-tryptophan salt compound, a citric acid-phenylalanine salt compound, a citric acid-isoleucine salt compound, a citric acid-leucine salt compound, a citric acid-valine salt compound, a citric acid-2-hydroxy-4-methylthiobutanoic acid salt compound, a citric acid-taurine salt compound are prepared, respectively, the structures of the above divalent metal salt compounds using citric acid as a substrate are shown in fig. 3, and the preparation conditions and results are shown in the following table 1:
TABLE 1
EXAMPLE 7 preparation of calcium malate-glycinate Co-salt
67.72 g (0.5 mol) of anhydrous malic acid white crystal with the mass percent of 99% and 200 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and malic acid is completely dissolved, so that an aqueous solution of malic acid with the mass percent of 25.0% is obtained. 77.08 g (1.0 mol) of calcium hydroxide powder with the mass percent of 96% is added into the malic acid water solution, the reaction temperature is increased to 80 ℃, the reaction is carried out for 0.5h under the condition of heat preservation and stirring, and the pH value of the reaction system is 12, thus obtaining the milky calcium malate water solution. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the calcium malate aqueous solution, the temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 4 hours, the pH value of the reaction system is 8.5, and the malic acid-calcium glycinate compound aqueous solution is obtained. The obtained malic acid-calcium glycine co-salt compound aqueous solution is directly decompressed and concentrated to be solid, then the solid is completely transferred into a tray, and is put into a blast drying oven at 105 ℃ to be dried to constant weight, 190.05 g of malic acid-calcium glycine co-salt compound white solid powder is obtained, the mass percentage of calcium in the product is 21.05%, and the yield is calculated to be 100%.
EXAMPLE 8 preparation of malic acid-magnesium Glycine Co-salt
67.72 g (0.5 mol) of anhydrous malic acid white crystal with the mass percent of 99% and 200 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and malic acid is completely dissolved, so that an aqueous solution of malic acid with the mass percent of 25.0% is obtained. 63.04 g (1.0 mol) of 92% magnesium hydroxide powder is added into the malic acid aqueous solution, the reaction temperature is raised to 85 ℃, the mixture is stirred and reacted for 1h while keeping the temperature, and the pH of the reaction system is 12, thus obtaining a milky magnesium malate aqueous solution. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the magnesium malate aqueous solution, the temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 2 hours, the pH value of the reaction system is 8.0, and the malic acid-magnesium glycinate compound aqueous solution is obtained. The obtained malic acid-magnesium glycinate compound aqueous solution is directly decompressed and concentrated to be solid, then the solid is completely transferred into a tray, and the tray is put into a blast drying oven at 100 ℃ to be dried to constant weight, 169.63 g of malic acid-magnesium glycinate compound white solid powder is obtained, the mass percentage of magnesium in the product is 14.15%, and the yield is calculated to be 100%.
EXAMPLE 9 preparation of malic acid-Zinc glycinate Co-salt
67.72 g (0.5 mol) of anhydrous malic acid white crystal with the mass percent of 99% and 200 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and malic acid is completely dissolved, so that an aqueous solution of malic acid with the mass percent of 25.0% is obtained. 101.45 g (1.0 mol) of zinc hydroxide powder with the mass percent of 98% is added into the malic acid water solution, the reaction temperature is raised to 85 ℃, the reaction is carried out for 2 hours under heat preservation and stirring, and the pH value of the reaction system is 8.0, thus obtaining milky zinc malate water solution. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the zinc malate aqueous solution, the temperature is raised to 110 ℃, the temperature is kept, the stirring reaction is carried out for 2 hours, the pH of the reaction system is 6.5, and the malic acid-zinc glycinate compound aqueous solution is obtained. The obtained malic acid-zinc glycinate compound aqueous solution is directly decompressed and concentrated to be solid, then the solid is completely transferred into a tray, and the tray is put into a blast drying oven at 100 ℃ to be dried to constant weight, 209.23 g of malic acid-zinc glycinate compound white solid powder is obtained, the mass percentage of zinc in the product is 31.07%, and the yield is calculated to be 100%.
EXAMPLE 10 preparation of copper malate-glycinate Co-salt
67.72 g (0.5 mol) of anhydrous malic acid white crystal with the mass percent of 99% and 200 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and malic acid is completely dissolved, so that an aqueous solution of malic acid with the mass percent of 25.0% is obtained. 80.35 g (1.0 mol) of copper oxide black powder with the mass percent of 99% is added into the malic acid water solution, the reaction temperature is raised to 85 ℃, the reaction is carried out for 2 hours under heat preservation and stirring, and the pH value of the reaction system is 7.5, thus obtaining the blue copper malate water solution with black precipitate. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the copper malate aqueous solution, the temperature is raised to 110 ℃, the temperature is kept, the stirring reaction is carried out for 4 hours, the pH value of the reaction system is 6.0, and the blue malic acid-copper glycinate co-salt compound aqueous solution is obtained. The obtained malic acid-copper glycinate compound aqueous solution is directly decompressed and concentrated to be solid, then the solid is completely transferred into a tray, and the tray is put into a blast drying oven at 105 ℃ to be dried to constant weight, 209.84 g of malic acid-copper glycinate compound blue solid powder is obtained, the mass percentage of copper in the product is 30.26%, and the yield is calculated to be 100%.
EXAMPLE 11 preparation of malic acid-ferrous Glycine Co-salt
67.72 g (0.5 mol) of anhydrous malic acid white crystal with the mass percent of 99% and 200 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and malic acid is completely dissolved, so that an aqueous solution of malic acid with the mass percent of 25.0% is obtained. 72.73 g (1.0 mol) of ferrous oxide black powder with the mass percent of 99 percent is added into the malic acid water solution, the reaction temperature is raised to 70 ℃, the reaction is carried out for 1h under the condition of heat preservation and stirring, and the pH value of the reaction system is 7.5, thus obtaining the yellowish ferrous malate water solution with black sediment. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the ferrous malate aqueous solution, the temperature is raised to 70 ℃, the temperature is kept, the stirring reaction is carried out for 2 hours, the pH value of the reaction system is 7.0, and the yellowish malic acid-ferrous glycinate compound aqueous solution is obtained. The obtained malic acid-ferrous glycine co-salt compound aqueous solution is directly decompressed and concentrated to be solid, then the solid is completely transferred into a tray, and is put into a blast drying oven at 105 ℃ to be dried to constant weight, 204.21 g of malic acid-ferrous glycine co-salt compound blue solid powder is obtained, the mass percentage of iron in the product is 27.42%, and the yield is calculated to be 100%.
EXAMPLE 12 preparation of citric acid-manganese Glycine Co-salt
67.72 g (0.5 mol) of anhydrous malic acid white crystal with the mass percent of 99% and 200 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and malic acid is completely dissolved, so that an aqueous solution of malic acid with the mass percent of 25.0% is obtained. 71.65 g (1.0 mol) of manganese monoxide gray green powder with the mass percent of 99% is added into the malic acid water solution, the reaction temperature is increased to 90 ℃, the reaction is carried out for 4 hours under the condition of heat preservation and stirring, and the pH value of the reaction system is 7.0, thus obtaining the light gray manganese malate water solution. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the manganese malate aqueous solution, the temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 2 hours, the pH value of the reaction system is 6.0, and the light gray malic acid-manganese glycinate co-salt compound aqueous solution is obtained. The obtained malic acid-manganese glycinate compound aqueous solution is directly decompressed and concentrated to be solid, then the solid is completely transferred into a tray, and the tray is put into a blast drying oven at 100 ℃ to be dried to constant weight, 201.08 g of malic acid-manganese glycinate compound off-white solid powder is obtained, the mass percentage of manganese in the product is 27.35%, and the yield is calculated to be 100%.
The structures of the malic acid-methionine co-salt compound, the malic acid-threonine co-salt compound, the malic acid-glutamic acid co-salt compound, the malic acid-lysine co-salt compound, the malic acid-tryptophan co-salt compound, the malic acid-phenylalanine co-salt compound, the malic acid-isoleucine co-salt compound, the malic acid-leucine co-salt compound, the malic acid-valine co-salt compound, the malic acid-2-hydroxy-4-methylthiobutanoic acid co-salt compound, and the malic acid-taurine co-salt compound are shown in fig. 4, and the preparation conditions and the results are shown in the following table 2:
/>
TABLE 2
EXAMPLE 13 preparation of calcium gluconate-glycinate Co-salts
198.14 g (1.0 mol) of anhydrous gluconic acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and the gluconic acid is completely dissolved, so as to obtain an aqueous solution of the gluconic acid with the mass percent of 25.21%. 101.0 g (1.0 mol) of calcium carbonate powder with the mass percent of 99 percent is added into the gluconic acid aqueous solution, the reaction temperature is increased to 90 ℃, the temperature is kept, the stirring reaction is carried out for 3 hours, the pH of the reaction system is 7.5, and the milky white calcium gluconate aqueous solution is obtained. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the calcium gluconate aqueous solution, the temperature is raised to 110 ℃, the temperature is kept, the stirring reaction is carried out for 4 hours, the pH value of the reaction system is 7.0, and the calcium gluconate-calcium glycinate compound aqueous solution is obtained. The obtained aqueous solution of the citric acid-calcium glycine co-salt compound is directly concentrated to be solid under reduced pressure, then all the aqueous solution is transferred into a tray, and the tray is put into a blast drying oven at 105 ℃ to be dried to constant weight, thus 344.37 g of white solid powder of the gluconic acid-calcium glycine co-salt compound is obtained, the mass percentage of calcium in the product is 11.61%, and the yield is calculated to be 100%.
EXAMPLE 14 preparation of magnesium gluconate-glycinate Co-salt
198.14 g (1.0 mol) of anhydrous gluconic acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and the gluconic acid is completely dissolved, so as to obtain an aqueous solution of the gluconic acid with the mass percent of 25.21%. 63.04 g (1.0 mol) of 92% magnesium hydroxide powder is added into the aqueous solution of gluconic acid, the reaction temperature is increased to 90 ℃, the mixture is stirred and reacted for 1h while keeping the temperature, and the pH of the reaction system is 12, thus obtaining the milky aqueous solution of magnesium gluconate. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the magnesium gluconate aqueous solution, the temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 2 hours, the pH value of the reaction system is 7.5, and the magnesium gluconate-glycinate compound aqueous solution is obtained. The obtained aqueous solution of the citric acid-magnesium glycinate compound is directly concentrated to be solid under reduced pressure, then all the aqueous solution is transferred into a tray, and the tray is put into a blast drying oven at 105 ℃ to be dried to constant weight, thus 317.51 g of white solid powder of the gluconic acid-magnesium glycinate compound is obtained, the mass percentage of magnesium in the product is 7.6%, and the yield is calculated to be 100%.
EXAMPLE 15 preparation of gluconic acid-zinc glycinate Co-salt
198.14 g (1.0 mol) of anhydrous gluconic acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and the gluconic acid is completely dissolved, so as to obtain an aqueous solution of the gluconic acid with the mass percent of 25.21%. 82.20 g (1.0 mol) of zinc oxide powder with the mass percent of 99 percent is added into the aqueous solution of the gluconic acid, the reaction temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 3 hours, the pH of the reaction system is 8.0, and the milky aqueous solution of the zinc gluconate is obtained. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the zinc gluconate aqueous solution, the temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 3 hours, the pH of the reaction system is 6.5, and the zinc gluconate-zinc glycinate compound aqueous solution is obtained. The obtained aqueous solution of the citric acid-zinc glycinate compound is directly concentrated to be solid under reduced pressure, then all the aqueous solution is transferred into a tray, and the tray is put into a blast drying oven at 105 ℃ to be dried to constant weight, thus 360.36 g of white solid powder of the gluconic acid-zinc glycinate compound is obtained, the mass percentage of zinc in the product is 18.04%, and the yield is calculated to be 100%.
EXAMPLE 16 preparation of copper gluconate-glycinate Co-salts
198.14 g (1.0 mol) of anhydrous gluconic acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and the gluconic acid is completely dissolved, so as to obtain an aqueous solution of the gluconic acid with the mass percent of 25.21%. 80.35 g (1.0 mol) of copper oxide black powder with the mass percent of 99 percent is added into the aqueous solution of the gluconic acid, the reaction temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 3 hours, the pH value of the reaction system is 7.5, and the blue aqueous solution of the copper gluconate with black sediment is obtained. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the copper gluconate aqueous solution, the temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 3 hours, the pH value of the reaction system is 6.5, and the copper gluconate-glycinate compound aqueous solution is obtained. The obtained aqueous solution of the citric acid-copper glycinate compound is directly concentrated to be solid under reduced pressure, then all the aqueous solution is transferred into a tray, and the tray is put into a blast drying oven at 105 ℃ to be dried to constant weight, thus 361.50 g of blue solid powder of the gluconic acid-copper glycinate compound is obtained, the mass percentage of copper in the product is 17.56%, and the yield is calculated to be 100%.
EXAMPLE 17 preparation of gluconic acid-ferrous Glycine Co-salt
198.14 g (1.0 mol) of anhydrous gluconic acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and the gluconic acid is completely dissolved, so as to obtain an aqueous solution of the gluconic acid with the mass percent of 25.21%. 72.73 g (1.0 mol) of ferrous oxide black powder with the mass percent of 99 percent is added into the gluconic acid aqueous solution, the reaction temperature is increased to 80 ℃, the reaction is carried out for 3 hours under the condition of heat preservation and stirring, and the pH value of the reaction system is 7.0, thus obtaining the light yellow ferrous gluconate aqueous solution with black sediment. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the ferrous gluconate aqueous solution, the temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 3 hours, the pH value of the reaction system is 6.5, and the aqueous solution of the gluconic acid-ferrous glycinate compound is obtained. The obtained aqueous solution of the citric acid-ferrous glycine co-salt compound is directly concentrated to be solid under reduced pressure, then all the aqueous solution is transferred into a tray, and the tray is put into a blast drying oven at 105 ℃ to be dried to constant weight, thus 353.77 g of pale yellow solid powder of the gluconic acid-ferrous glycine co-salt compound is obtained, the mass percentage of iron in the product is 15.83%, and the calculated yield is 100%.
EXAMPLE 18 preparation of gluconic acid-manganese glycinate Co-salt
198.14 g (1.0 mol) of anhydrous gluconic acid crystal with the mass percent of 99% and 580 g of deionized water are weighed into a reaction bottle with a stirrer, stirred and heated to 50 ℃, and the gluconic acid is completely dissolved, so as to obtain an aqueous solution of the gluconic acid with the mass percent of 25.21%. 93.63 g (1.0 mol) of white manganese hydroxide powder with the mass percent of 95 percent is added into the aqueous solution of the gluconic acid, the reaction temperature is increased to 80 ℃, the reaction is carried out for 3 hours under the condition of heat preservation and stirring, and the pH value of the reaction system is 7.5, thus obtaining the aqueous solution of the manganese gluconate with light green precipitation. 75.76 g (1.0 mol) of glycine crystal with the mass percent of 99 percent is added into the manganese gluconate aqueous solution, the temperature is raised to 100 ℃, the temperature is kept, the stirring reaction is carried out for 3 hours, the pH value of the reaction system is 6.0, and the aqueous solution of the gluconic acid-manganese glycinate compound is obtained. The obtained citric acid-manganese glycinate compound aqueous solution is directly concentrated to be solid under reduced pressure, then all the solid solution is transferred into a tray, and the tray is put into a blast drying oven at 105 ℃ to be dried to constant weight, thus 356.41 g of off-white solid powder of the gluconic acid-manganese glycinate compound is obtained, the mass percentage of manganese in the product is 15.43%, and the yield is calculated to be 100%.
The structures of the gluconic acid-methionine salt compound, the gluconic acid-threonine salt compound, the gluconic acid-glutamic acid salt compound, the gluconic acid-lysine salt compound, the gluconic acid-tryptophan salt compound, the gluconic acid-phenylalanine salt compound, the gluconic acid-isoleucine salt compound, the gluconic acid-leucine salt compound, the gluconic acid-valine salt compound, the malic acid-2-hydroxy-4-methylthiobutanoic acid salt compound and the gluconic acid-taurine salt compound, which are shown in the figure 5, are prepared under the following conditions and with the following results
The table 3 describes:
/>
TABLE 3 Table 3
In tables 1 to 3, the values before the slash are the temperature, time and pH at which the α -hydroxy organic acid reacts with the divalent metal compound in the first reaction, and the values after the slash are the temperature, time and pH at which the α -amino acid and the like are added in the second reaction. The products prepared in examples 1-18 were tested for solubility and were found to all have a solubility of less than 1.5 g/100 ml water (20 ℃).
Example 19: biological effect experimental comparison of divalent Metal Co-salt Compounds of partial alpha-hydroxy organic acids-amino acids and analogs thereof
The rainbow trout is taken as an experimental feeding target, and free amino acids (calcium salt compounds and magnesium salt compounds are not microelements, so that the comparison is mainly free amino acids) and inorganic salt microelements are taken as comparison. The rainbow trout is fed by using the divalent metal trace element co-salt compound of the trace elements in the form of sulfate and the alpha-hydroxy organic acid-amino acid and analogues thereof respectively, and the result shows that: the deposition amount of trace elements in divalent metal trace element co-salt compounds of alpha-hydroxy organic acid-amino acid and analogues thereof is significantly higher than that of inorganic salt groups. The effective utilization rate of amino acids for alpha-hydroxy organic acid-amino acid and its analog calcium co-salt compound and alpha-hydroxy organic acid-amino acid and its analog magnesium co-salt compound is significantly higher than that of the free amino acid group. The experimental results are shown in Table 4.
/>
TABLE 4 Table 4
Example 20: experiment of stability of partial alpha-hydroxy organic acid-amino acid and its analog divalent Metal Co-salt Compound against vitamin A and B1
The effect of trace elements in the premix on vitamin A and B1 stability is shown in Table 5.
TABLE 5
The data in table 5 shows that the alpha-hydroxy organic acid-amino acid and its analog divalent metal co-salt compounds of the present invention are less damaging to vitamins a and B1 than the inorganic salt group and significantly reduce the loss of vitamins a and B1 in the premix.
In conclusion, the alpha-hydroxy organic acid-amino acid and analogue divalent metal salt compound thereof has higher bioavailability, can avoid the dissolution loss of amino acid and alpha-hydroxy organic acid in feed in water environment, further avoid water pollution, and avoid the damage of divalent metal to vitamins and fatty compounds in feed, and can be applied to aquatic feed or poultry feed as an additive.
The above embodiments are only for illustrating the technical solution of the present invention and not for limiting the same, and although the present invention has been described in detail with reference to the preferred embodiments, it should be understood by those skilled in the art that modifications and equivalents may be made thereto without departing from the spirit and scope of the technical solution of the present invention, which is intended to be covered by the scope of the claims of the present invention. The technology, shape, and construction parts of the present invention, which are not described in detail, are known in the art.
Claims (9)
1. An α -hydroxy organic acid-amino acid and analogs thereof divalent metal co-salt compound, characterized in that said divalent metal co-salt compound has the general structure:
wherein M is any one of calcium, magnesium, zinc, copper, iron and manganese; r is R 1 Can form an alpha-hydroxy organic acid with an alpha-hydroxy carboxyl group, R 2 Can form alpha-amino acid and amino acid analogues thereof with alpha-amino carboxyl, x is 0.5 or 1, y is 1 or 2, and z is 0-2.
2. The α -hydroxy organic acid-amino acid and analog divalent metal co-salt compound according to claim 1, wherein the α -hydroxy organic acid is any one of citric acid, malic acid, gluconic acid;
the alpha-amino acid is any one of glycine, D, L-methionine, L-threonine, L-glutamic acid, L-lysine, L-tryptophan, L-phenylalanine, L-isoleucine, L-leucine and L-valine;
the amino acid analogue is any one of 2-hydroxy-4-methylthiobutanoic acid and taurine.
3. A process for the preparation of divalent metal co-salt compounds of α -hydroxy organic acids-amino acids and analogues thereof, said process comprising the steps of:
reacting the alpha-hydroxy organic acid aqueous solution with the divalent metal compound for 0.5-3 h at the reaction temperature of 60-100 ℃ and the pH value of 7.0-12 to obtain a mixed aqueous solution of the divalent metal salt of the alpha-hydroxy organic acid and the divalent metal compound;
adding alpha-amino acid and analogues thereof into the mixed aqueous solution of the divalent metal salt and the divalent metal compound of the alpha-hydroxy organic acid, and reacting for 1-4 hours at the reaction temperature of 70-110 ℃ with the pH value of 6.0-11 to obtain the mixed aqueous solution of the divalent metal co-salt compound of the alpha-hydroxy organic acid-amino acid and analogues thereof;
concentrating the mixed aqueous solution of the alpha-hydroxy organic acid-amino acid and the analogue divalent metal co-salt compound to be solid under reduced pressure, drying to be constant weight, grinding and sieving to obtain the alpha-hydroxy organic acid-amino acid and the analogue divalent metal co-salt compound.
4. A method of preparation according to claim 3, wherein the divalent metal compound is an oxide or hydroxide or carbonate of any one of calcium, magnesium, zinc, copper, iron, manganese.
5. The method according to claim 3, wherein the molar ratio of the α -hydroxy organic acid to the α -amino acid and the like is 0.5 to 1:1, and the molar ratio of the ligand consisting of the α -hydroxy organic acid to the α -amino acid and the like to the divalent metal is 1:1 to 2.
6. The method according to claim 5, wherein when the α -hydroxy organic acid is citric acid, the molar ratio of the α -hydroxy organic acid to the amino acid and the like is 1:1, and the molar ratio of the ligand to the divalent metal compound is 1:1.
7. The method according to claim 5, wherein when the α -hydroxy organic acid is malic acid, the molar ratio of the α -hydroxy organic acid to the amino acid and the analogues thereof is 0.5:1, and the molar ratio of the ligand to the divalent metal compound is 1.5:1.
8. The method according to claim 5, wherein when the α -hydroxy organic acid is gluconic acid, the molar ratio of the α -hydroxy organic acid to the amino acid and the analogues thereof is 1:1, and the molar ratio of the divalent metal compound to the ligand is 2:1.
9. Use of an α -hydroxy organic acid-amino acid and its analogue divalent metal co-salt compound according to claim 1 or 2 or prepared according to the preparation method of any one of claims 3-8 as an additive in the preparation of aquatic feed or poultry feed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310341680.2A CN116573999A (en) | 2023-03-31 | 2023-03-31 | Alpha-hydroxy organic acid-amino acid and analogue divalent metal co-salt compound thereof, and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310341680.2A CN116573999A (en) | 2023-03-31 | 2023-03-31 | Alpha-hydroxy organic acid-amino acid and analogue divalent metal co-salt compound thereof, and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116573999A true CN116573999A (en) | 2023-08-11 |
Family
ID=87540280
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310341680.2A Pending CN116573999A (en) | 2023-03-31 | 2023-03-31 | Alpha-hydroxy organic acid-amino acid and analogue divalent metal co-salt compound thereof, and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116573999A (en) |
-
2023
- 2023-03-31 CN CN202310341680.2A patent/CN116573999A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100609526B1 (en) | Metal complexes of alpha amino dicarboxylic acids | |
US5061815A (en) | Metal lysine complexes and method for producing metal lysine complexes | |
US5631031A (en) | Water-insoluble amino acid salt | |
JP5819519B2 (en) | Complexes of mixed amino acids with metal salts | |
JPH11292761A (en) | Amino acid chelate for animal growth promotion | |
EP1158869B1 (en) | Chelated food additive and method of preparation thereof | |
WO2009089493A2 (en) | Nitrate amino acid chelates | |
BR102015029710A2 (en) | chelated minerals with soy amino acids | |
CN116573999A (en) | Alpha-hydroxy organic acid-amino acid and analogue divalent metal co-salt compound thereof, and preparation method and application thereof | |
EP1266901B1 (en) | Preparation of metal complexes of amino acids obtained by hydrolysis of soy protein | |
CN105813470B (en) | Use of ethylenediamine metal complexes to deliver highly absorbable metals for animal nutrition | |
CN113841795A (en) | Self-assembled small peptide chelated copper feed additive and preparation method thereof | |
JP2002047266A (en) | Composition including methionine transition metal complex and amino acids | |
CN115260068A (en) | Divalent metal eutectic compound taking hydroxy methionine as film base and preparation method and application thereof | |
CN116589370A (en) | Alpha-amino acid-metal phosphate co-salt compound, and preparation method and application thereof | |
CN116355040A (en) | Amino acid glycine dipeptide compound and preparation method and application thereof | |
CN113678947A (en) | Self-assembled small peptide chelated manganese feed additive and preparation method thereof | |
CN109793111A (en) | A kind of preparation method of the threonine chelated ferrous iron of feed | |
UA5714U (en) | method for rising productivity of poultry by adding to feed composition chelate microelements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |